Decreased neuronal nitric oxide synthase messenger RNA and somatostatin messenger RNA in the striatum of Huntington's disease

Neuroscience

Volumn 72, Issue 4, 1996, Pages 1037-1047

  Norris, P J ^a,d   Waldvogel, H J ^b   Faull, R L M ^b   Love, D R ^c   Emson, P C ^a  

^a BABRAHAM INSTITUTE   (United Kingdom)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

^d MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

Huntington's disease; in situ hybridization; nitric oxide; nitric oxide synthase; somatostatin; striatum

Indexed keywords

MESSENGER RNA; NEUROPEPTIDE Y; NITRIC OXIDE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE; SOMATOSTATIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; HUMAN; HUMAN TISSUE; HUNTINGTON CHOREA; IN SITU HYBRIDIZATION; INTERNEURON; MALE; NERVE DEGENERATION; PRIORITY JOURNAL;

EID: 0029966584     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4522(95)00596-X     Document Type: Article

References (55)

1. Albin R. L., Reiner A., Anderson K. D., Dure L. S., Handelin B., Balfour R., Whetsell W. O., Penney J. B. and Young A. B. (1992) Preferential loss of striato-external pallidal projection neurones in presymptomatic Huntington's disease. Ann. Neurol. 31, 425-430.
2. Aronin N., Cooper P. E., Lorenz L. J., Bird E. D., Sagar S. M., Leeman S. E. and Martin J. B. (1983) Somatostatin is increased in the basal ganglia in Huntington's disease. Ann. Neurol. 13, 519-526.
3. Augood S. J., Herbison A. E. and Emson P. C. (1995) Localization of GAT-1 GABA transporter mRNA in rat striatum: cellular coexpression with GAD67 mRNA, GAD67 immunoreactivity, and parvalbumin mRNA. J. Neurosci. 15, 865-874.
4. Augood S. J., McGowan E. M. and Emson P. C. (1994) Expression of N-methyl-D-aspartate receptor subunit NR1 messenger RNA by identified striatal somatostatin cells. Neuroscience 59, 7-12.
5. Beal M. F., Kowall N. W., Swartz K. J., Ferrante R. J. and Martin J. B. (1989) Differential sparing of somatostatin neuropeptide Y and cholinergic neurons following striatal excitotoxin lesions. Synapse 3, 38-47.
6. Beal M. F., Mazurek M. F., Ellison D. W., Swartz K. J., McGarvey U., Bird E. D. and Martin J. B. (1988) Somatostatin and neuropeptide Y concentrations in pathologically graded cases of Huntington's disease. Ann. Neurol. 23, 562-569.
7. Boegman R. J., Smith Y. and Parent A. (1987) Quinolinic acid does not spare striatal neuropeptide Y-immunoreactive neurons. Brain Res. 415, 178-182.
8. Bredt D. S., Glatt C. E., Hwang P. M., Fotuhi M., Dawson T. M. and Snyder S. H. (1991) Nitric oxide synthase protein and messenger RNA are discretely localized in neuronal populations of the mammalian CNS together with NADPH diaphorase. Neuron 7, 615-624.
9. Buisson A., Margail I., Allix M., Callebert J., Plotkine M. and Boulu R. G. (1992) Role of nitric oxide in focal ischemia. In Pharmacology of Cerebral Ischemia 1992 (eds Krieglstein J. and Oberpickler-Schwenk H.), pp. 417-425. Wissenschftliche Verlagsgesellschaft mbH, Stuttgart.
10. Chesselet M. F. and Graybiel A. M. (1986) Striatal neurons expressing somatostatin-like immunoreactivity: evidence for a peptidergic interneuronal system in the cat. Neuroscience 17, 547-571.
11. Choi D. W. (1992) Nitric oxide: foe or friend to the injured brain? Proc. natn. Acad. Sci. U.S.A. 90, 9741-9743.
12. Davies S. W. and Roberts P. J. (1987) No evidence for preservation of somatostatin-containing neurones after intrastriatal injections of quinolinic acid. Nature 327, 326-329.
13. Dawbarn D., De Quidt M. E. and Emson P. C. (1985) Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington's disease. Brain Res. 340, 251-260.
14. Dawson V. L., Dawson T. M., London E. D., Bredt D. S. and Snyder S. H. (1991) Nitric oxide mediates glutamate neurotoxicity in primary cortical culture. Proc. natn. Acad. Sci. U.S.A. 88, 6368-6371.
15. Emson P. C., Arregui A., Clement-Jones V., Sandberg B. E. B. and Rossor M. (1980) Regional distribution of methionine-enkephalin and substance P-like immunoreactivity in normal human brain and in Huntington's disease. Brain Res. 199, 147-160.
16. Ferrante R. J., Kowall N. W., Beal M. F., Martin J. B., Bird E. D. and Richardson E. P. (1987) Morphologic and histochemical characteristics of a spared subset of striatal neurons in Huntington's disease. J. Neuropath. exp. Neurol. 46, 12-27.
17. Folstein S. E. (1989) Huntington's Disease: A Disorder of Families. The Johns Hopkins University Press, Baltimore, MD.
18. Graybiel A. M. (1990) Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci. 13, 244-254.
19. Hoogeveen A. T., Willemsen R., Meyer N., de Rooij K. E., Roos R. A. C., van Ommen G.-J. B. and Galjaard H. (1993) Characterization and localization of the Huntington disease gene product. Human molec. Genet. 2, 2067-2073.
20. Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72, 971-983.
21. Kadowaki K., Kishimoto J., Leng G. and Emson P. C. (1994) Up-regulation of nitric oxide synthase (NOS) gene expression together with NOS activity in the rat hypothalamo-hypophysieal system after chronic salt loading: evidence of a neuromodulatory role of nitric oxide in arginine vasopressin and oxytocin secretion. Endocrinology 134, 1011-1017.
22. Kowall N. W., Ferrante R. J., Beal M. F., Richardson E. P., Sofroniew M. V., Cuello A. C. and Martin J. B. (1987) Neuropeptide Y. somatostatin, and reduced nicotinamide adenine dinucleotide phosphate diaphorase in the human striatum: a combined immunocytochemical and enzyme histochemical study. Neuroscience 20, 817-828.
23. Kowall N. W., Ferrante R. J. and Martin J. B. (1987) Patterns of cell loss in Huntington's disease. Trends Neurosci. 10, 24-29.
24. Li S.-H., Schilling G., Young W. S., Li X. J., Margolis R. L., Stine O. C., Wagster M. V., Abbott M. H., Franz M. L., Ranen N. G., Folstein S. E., Hedreen J. C. and Ross C. A. (1993) Huntington's disease gene (IT15) is widely expressed in human and rat tissues. Neuron 11, 985-993.
25. Mackenzie M. G., Jenner P. and Marsden C. D. (1995) The effect of nitric oxide synthase inhibition on quinolinic acid toxicity in the rat striatum. Neuroscience 67, 357-371.
26. Mann D. M. A., Oliver R. and Snowden J. S. (1993) The topographical distribution of brain atrophy in Huntington's disease and progressive nuclear palsy. Acta neuropath. 85, 553-559.
27. Mengod G., Rigo M., Savasta A., Probst A. and Palacios J. M. (1992) Regional distribution of neuropeptide somatostatin gene expression in the human brain. Synapse 12, 62-74.
28. Morton A. J., Nicholson L. F. B. and Faull R. L. M. (1993) Compartmental loss of NADPH diaphorase in the neuropil of the human striatum in Huntington's disease. Neuroscience 53, 159-168.
29. Nakane M., Schmidt H. H., Pollock J. S., Förstermann U. and Murad F. (1993) Cloned human brain nitric oxide synthase is highly expressed in skeletal muscle. Fedn Eur. biochem. Socs Lett. 316, 175-180.
30. Nathan C. and Xie Q.-W. (1994) Nitric oxide synthases: roles, tolls and controls. Cell 78, 915-918.
31. Nisbet A. P., Foster O. J. F., Kingsbury A., Lees A. J. and Marsden C. D. (1994) Nitric oxide synthase mRNA expression in human subthalamic nucleus, striatum and globus pallidus: implications for basal ganglia function. Molec. Brain Res. 22, 329-332.
32. Norris P. J., Hardwick J. P. and Emson P. C. (1994) Localization of NADPH cytochrome P450 oxidoreductase in rat brain by immunohistochemistry and in situ hybridization and a comparison with the distribution of neuronal NADPH-diaphorase staining. Neuroscience 61, 331-350.
33. Prado R., ElDeiry L. Valdez I., Dietrich W. D., Busto R. and Globus M. Y.-T. (1993) Effect of nitric oxide synthase inhibition on lesion volume following intrastriatal N-methyl-D-aspartate injection. J. cerebr. Blood Flow Metab. 13, S639 (abstract).
34. Qin Y., Soghomonian J.-J. and Chesselet M.-F. (1992) Effects of quinolinic acid on messenger RNAs encoding somatostatin and glutamic acid decarboxylase in the striatum of adult rats. Expl Neurol. 115, 200-211.
35. Quarrell O. and Harper P. (1991) Huntington's Disease. W. B. Saunders, Philadelphia.
36. Reiner A., Albin R. L., Anderson K. D., D'Amato C. J., Penney J. B. and Young A. B. (1988) Differential loss of striatal projection neurons in Huntington disease. Proc. natn. Acad. Sci. U.S.A. 85, 5733-5737.
37. Reiner A. and Anderson K. D. (1990) The patterns of neurotransmitter and neuropeptide co-occurrence among striatal neurons. Conclusions based on recent findings. Brain Res. Rev. 15, 251-265.
38. Roberts R. C., Ahn A., Swartz K. J., Beal M. F. and DiFiglia M. (1993) Intrastriatal injections of quinolinic acid or kainic acid: differential patterns of cell survival and the effects of data analysis on the outcome. Expl Neurol. 124, 274-282.
39. Salin P., Mercugliano M. and Chesselet M.-F. (1990) Differential effects of chronic treatment with haloperidol and clozapine on the level of preprosomatostatin mRNA in the striatum, nucleus accumbens, and frontal cortex of the rat. Cell. molec. Neurobiol. 10, 127-144.
40. Sapp E., Ge P., Aizawa H., Bird E., Penney J., Young A. B., Vonsattel J.-P. and Difiglia M. (1995) Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington's disease using high resolution image analysis. Neuroscience 64, 397-404.
41. Schmidt W., Wolf G., Calka J. and Schmidt H. H. H. W. (1995) Evidence for bidirectional changes in nitric oxide synthase activity in the rat striatum after excitotoxically (quinolinic acid) induced degeneration. Neuroscience 67, 345-356.
42. L Schuman E. M. and Madison D. V. (1994) Nitric oxide and synaptic function. A. Rev. Neurosci. 17, 153-183.
43. Selden N., Geula C., Hersh L. and Mesulam M.-M. (1994) Human striatum: chemoarchitecture of the caudate nucleus, putamen and ventral striatum in health and Alzheimer's disease. Neuroscience 60, 621-636.
44. Shen L. P., Pictet R. L. and Rutter W. J. (1982) Human somatostatin I: sequence of the cDNA. Proc. natn. Acad Sci. U.S.A. 79, 4575-4579.
45. Shen L. P. and Rutter W. J. (1984) Sequence of the human somatostatin I gene. Science 224, 168-171.
46. Siegel S. (1956) Nonparametric Statistics for the Behavioural Sciences. McGraw-Hill, New York.
47. Strong T. V., Tagle D. A., Valdes J. M., Elmer L. W., Boehm K., Swaroop M., Kaatz K. W., Collins K. S. and Albin R. L. (1993) Widespread expression of the human and rat Huntington's disease gene in brain and non-neural tissues. Nature Genet. 5, 259-265.
48. Tomlinson B. E. and Corsellis J. A. N. (1994) Ageing and dementias. In Greenfield's Neuropathology (eds Hume Adams J., Corsellis J. A. N. and Duchen L. W.), pp. 951-1025. Edward Arnold, London.
49. Uemura Y., Kowall N. W. and Beal M. F. (1990) Selective sparing of NADPH-diaphorase-somatostatin-neuropeptide Y neurons in ischemic gerbil striatum. Ann. Neurol. 27, 620-625.
50. Verge V. M. K., Xu Z. and Xu X.-J. (1992) Marked increase in nitric oxide synthase mRNA in rat dorsal root ganglia after peripheral axotomy: in situ hybridization and functional studies. Proc. natn. Acad. Sci. U.S.A. 89, 11,617-11,672.
51. Vincent S. R. and Johansson O. (1983) Striatal neurons containing both somatostatin and avian pancreatic polypeptide (App)-like immunoreactivities and NADPH diaphorase activity: a light and electron microscopic study. J. comp. Neurol. 217, 264-270.
52. Vincent S. R., Johansson O., Hokfelt T., Skirboll L., Elde R. P., Terenius L., Kimmel J. and Goldstein M. (1983) NADPH diaphorase: a selective histochemical marker for striatal neurons containing both somatostatin and avian pancreatic polypeptide (APP)-like immunoreactivities. J. comp. Neurol. 217, 252-263.
53. Vonsattel J.-P., Myers R. H., Stevens T. J., Ferrante R. J., Bird E. D. and Richardson E. P. J. (1985) Neuropathological classification of Huntington's disease. J. Neuropath. exp. Neurol. 44, 559-577.
54. Warner J. P., Barron L. H. and Brock D. J. H. (1993) A new polymerase chain reaction (PCR) assay for the trinucleotide repeat that is unstable and expanded on Huntington's disease chromosomes. Molec. cell. Probes 7, 235-239.
55. Young A. B., Greenamyre J. T., Hollingsworth Z., Albin R., D'Amato C., Shoulson I. and Penney J. B. (1988) NMDA receptor losses in putamen from patients with Huntington's disease. Science 241, 981-983.